Term: Drug Program Information Network (DPIN)

Printer friendly

Glossary Definition

Last Updated: 2010-10-22

Definition:

DPIN is an electronic, on-line, point-of-sale drug system. It links all community pharmacies (but not pharmacies in hospitals or nursing homes/personal care homes) and captures information about all Manitoba residents, including most prescriptions dispensed to residents holding First Nation status. DPIN contains information such as unique patient identification, age, birthdate, sex, medication history, over-the-counter (OTC) medication history, patient postal code, new drugs prescribed, date dispensed, and unique pharmacy identification number. DPIN is maintained by the Government of Manitoba's Ministry of Health.

NOTE: In the Health Inequities deliverable (Martens et al., 2010), it was reported that up until the year 2005, northern First Nations community pharmaceutical data may be missing due to lack of prescription data being entered into the DPIN system. However, as of 2005 to the present, prescriptions for First Nations communities are dispensed through a private pharmaceutical company that reports all prescriptions through DPIN.

NOTE: See the Drug Program Information Network (DPIN) Data glossary term for more information.

Related concepts 

• Calculating Costs/Expenditures for Pharmaceuticals
• Creating Drug Identification Number (DIN) Lists Using the SPD Server Updated DIN Master (UDM) File
• Family Income / Household Income - Extracting from DPIN Application Files

Related terms 

• Anatomical Therapeutic Chemical (ATC) Drug Classification System
• Dispensed Medications
• Drug Identification Number (DIN)
• Drug Identification Number (DIN) Master File
• Drug Program Information Network (DPIN) Data
• End of life Prescription Drugs
• Index Date (Drugs)
• Latent Tuberculosis Infection (LTBI)
• Manitoba IMPRxOVE Program
• Master (Common) Formulary
• Personal Health Identification Number (PHIN)
• Pharmacare Program
• Pharmaceutical Use / Prescription Rate
• Prescribed Days Supplied
• Prescription Cost
• Prescription Drug Claims
• Prescriptions

References 

• Doupe M, Brownell M, Kozyrskyj A, Dik N, Burchill C, Dahl M, Chateau D, De Coster C, Hinds A, Bodnarchuk J. Using Administrative Data to Develop Indicators of Quality Care in Personal Care Homes. Winnipeg, MB: Manitoba Centre for Health Policy, 2006. [Report] [Summary] [Additional Materials] (View)
• Martens P, Brownell M, Au W, MacWiliam L, Prior H, Schultz J, Guenette W, Elliott L, Buchan S, Anderson M, Caetano P, Metge C, Santos R, Serwonka K. Health Inequities in Manitoba: Is the Socioeconomic Gap in Health Widening or Narrowing Over Time? Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)

Term used in 

• Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98(12):2784-2788. [Abstract] (View)
• Bernstein CN, Blanchard JF, Metge C, Yogendran M. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol 2003;98(8):1797-1801. [Abstract] (View)
• Brownell M, Chartier M, Santos R, Ekuma O, Au W, Sarkar J, MacWilliam L, Burland E, Koseva I, Guenette W. How are Manitoba's Children Doing? Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
• Chartier M, Finlayson G, Prior H, McGowan K, Chen H, de Rocquigny J, Walld R, Gousseau M. Health and Healthcare Utilization of Francophones in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] (View)
• Doupe M, Kozyrskyj A, Soodeen R, Derksen S, Burchill C, Huq S. An Initial Analysis of Emergency Departments and Urgent Care in Winnipeg. Winnipeg, MB: Manitoba Centre for Health Policy, 2008. [Report] [Summary] [Additional Materials] (View)
• Finlayson G, Ekuma O, Yogendran M, Burland E, Forget E. The Additional Cost of Chronic Disease in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] (View)
• Fransoo R, Martens P, Prior H, Chateau D, McDougall C, Schultz J, McGowan K, Soodeen R, Bailly A. Adult Obesity in Manitoba: Prevalence, Associations, and Outcomes. Winnipeg, MB: Manitoba Centre for Health Policy, 2011. [Report] [Summary] (View)
• Fransoo R, Martens P, Burland E, The Need to Know Team, Prior H, Burchill C. Manitoba RHA Indicators Atlas 2009. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Report] [Summary] [Additional Materials] (View)
• Garland A, Fransoo R, Olafson K, Ramsey C, Yogendran M, Chateau D, McGowan K. The Epidemiology and Outcomes of Critical Illness in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] (View)
• Heaman M, Kingston D, Helewa M, Brownell M, Derksen S, Bogdanovic B, McGowan K, Bailly A. Perinatal Services and Outcomes in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] [Updates and Errata] (View)
• Katz A, Bogdanovic B, Soodeen R. Physician Integrated Network Baseline Evaluation: Linking Electronic Medical Records and Administrative Data. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] (View)
• Katz A, Chateau D, Bogdanovic B, Taylor C, McGowan K-L, Rajotte L, Dziadek J. Physician Integrated Network: A Second Look. Winnipeg, MB: Manitoba Centre for Health Policy, 2014. [Report] [Summary] [Updates and Errata] (View)
• Katz A, Bogdanovic B, Ekuma O, Soodeen RA, Chateau D, Burnett C. Physician Resource Projection Models . Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Report] [Summary] (View)
• Katz A, Martens P, Chateau D, Bogdanovic B, Koseva I, McDougall C, Boriskewich E. Understanding the Health System Use of Ambulatory Care Patients. Winnipeg, MB: Manitoba Centre for Health Policy, 2013. [Report] [Summary] (View)
• Katz A, De Coster C, Bogdanovic B, Soodeen R, Chateau D. Using Administrative Data to Develop Indicators of Quality in Family Practice. Winnipeg, MB: Manitoba Centre for Health Policy, 2004. [Report] [Summary] (View)
• Kozyrskyj A, Lix L, Dahl M, Soodeen R. High-cost Users of Pharmaceuticals: Who are They? Winnipeg, MB: Manitoba Centre for Health Policy, 2005. [Report] [Summary] (View)
• Martens P, Brownell M, Au W, MacWiliam L, Prior H, Schultz J, Guenette W, Elliott L, Buchan S, Anderson M, Caetano P, Metge C, Santos R, Serwonka K. Health Inequities in Manitoba: Is the Socioeconomic Gap in Health Widening or Narrowing Over Time? Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
• Martens P, Fransoo R, The Need to Know Team, Burland E, Prior H, Burchill C, Romphf L, Chateau D, Bailly A, Ouelette C. What Works? A First Look at Evaluating Manitoba's Regional Health Programs and Policies at the Population Level. Winnipeg, MB: Manitoba Centre for Health Policy, 2008. [Report] [Summary] [Additional Materials] (View)
• Martens PJ, Bartlett J, Burland E, Prior H, Burchill C, Huq S, Romphf L, Sanguins J, Carter S, Bailly A. Profile of Metis Health Status and Healthcare Utilization in Manitoba: A Population-Based Study. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
• Metge C, Black C, Peterson S, Kozyrskyj A, Roos NP, Bogdanovic B. Analysis of Patterns of Pharmaceutical Use in Manitoba, 1996: Key Findings - A POPULIS Project. Winnipeg, MB: Manitoba Centre for Health Policy and Evaluation, 1999. [Report] [Summary] (View)
• Metge C, Chateau D, Prior H, Soodeen R, De Coster C, Barre L. Composite Measures/Indices of Health and Health System Performance. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Report] [Summary] (View)
• Metge C, Kozyrskyj A, Dahl M, Yogendran M, Roos NP. Pharmaceuticals: Focussing on Appropriate Utilization. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
• Metge CJ, Blanchard JF, Peterson S, Bernstein CN. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001;96(12):3348-3355. [Abstract] (View)
• Raymond C, Metge C, Alessi-Severini S, Dahl M, Schultz J, Guenette W. Pharmaceutical Use in Manitoba: Opportunities to Optimize Use. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] (View)
• Santos R, Brownell M, Ekuma O, Mayer T, Soodeen R-A. The Early Development Instrument (EDI) in Manitoba: Linking Socioeconomic Adversity and Biological Vulnerability at Birth to Children's Outcomes at Age 5. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] (View)